Bristol-Myers Squibb (NYSE:BMY) Releases FY24 Earnings Guidance

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $0.75-0.95 for the period, compared to the consensus EPS estimate of $0.70. The company issued revenue guidance of +5% yr/yr to $47.26 billion, compared to the consensus revenue estimate of $46.78 billion. Bristol-Myers Squibb also […]

Leave a Reply

Your email address will not be published.

Previous post Shentu (CTK) Price Reaches $0.57
Next post Aerodrome Finance Achieves Self Reported Market Capitalization of $174.62 Million (AERO)